Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Epidermolysis Bullosa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02960997
What this trial is testing

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa Simplex KobnerWeber-Cockayne Syndrome
Stanford University 8
Large-scale testing (Phase 3)Study completedNCT02384460
What this trial is testing

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 169
Not applicableWithdrawnNCT04213703
What this trial is testing

A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa SimplexEpidermolysis Bullosa Dystrophica
ProgenaBiome
Testing effectiveness (Phase 2)UnknownNCT04140786
What this trial is testing

Optimizing IV Gentamicin in JEB

Who this might be right for
Junctional Epidermolysis Bullosa
University of Southern California 6
Testing effectiveness (Phase 2)Study completedNCT04644627
What this trial is testing

Topical Gentamicin Nonsense Suppression Therapy of EB

Who this might be right for
Epidermolysis Bullosa
Oslo University Hospital 4
Not applicableStudy completedNCT01716169
What this trial is testing

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Stanford University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06834035
What this trial is testing

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa AcquisitaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 8
Testing effectiveness (Phase 2)Looking for participantsNCT03526159
What this trial is testing

Gentamicin for Junctional Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis Bullosa
University of Southern California 6
Testing effectiveness (Phase 2)Study completedNCT02698735
What this trial is testing

Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
University of Southern California 5
Very early researchActive Not RecruitingNCT04171661
What this trial is testing

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
CHU de Quebec-Universite Laval 1
Large-scale testing (Phase 3)Active Not RecruitingNCT05464381
What this trial is testing

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Who this might be right for
Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 91
Testing effectiveness (Phase 2)Ended earlyNCT03578029
What this trial is testing

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaDystrophic Epidermolysis Bullosa
Lenus Therapeutics, LLC 4
Early research (Phase 1)Active Not RecruitingNCT06713434
What this trial is testing

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaEpidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa+1 more
Fundación DEBRA Chile, Niños Piel de Cristal 20
Testing effectiveness (Phase 2)Looking for participantsNCT07230223
What this trial is testing

Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaWound Heal
Isfahan University of Medical Sciences 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07482813
What this trial is testing

An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa (EB)
Paradigm Therapeutics 80
Testing effectiveness (Phase 2)Study completedNCT05143190
What this trial is testing

Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Phoenix Tissue Repair, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT01538862
What this trial is testing

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Vanderbilt University Medical Center 7
Early research (Phase 1)Study completedNCT05378997
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Who this might be right for
BlisterWound of SkinEpidermolysis Bullosa+1 more
Xinnate AB 35
Large-scale testing (Phase 3)Looking for participantsNCT06917690
What this trial is testing

Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaJunctional Epidermolysis BullosaEpidermolysis Bullosa, Dystrophic+7 more
Chiesi Farmaceutici S.p.A. 6
Testing effectiveness (Phase 2)Study completedNCT02582775
What this trial is testing

MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 17
Next Page